-
Mashup Score: 0CAR-T cell therapies for T cell malignancies: does cellular immunotherapy represent the best chance of cure? - 19 day(s) ago
Chimeric antigen receptor T cell (CAR-T) therapy has proven successful for B cell lymphomas and leukaemias. This success has inspired the development of CA
Source: ashpublications.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 44
Nature Medicine – Results of the phase 2 trial of CD19 CAR T cell therapy lisocabtagene maraleucel in patients with relapsed or refractory follicular lymphoma, most of whom were treated in a…
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet-
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study @NatureMedicine #lymsm #CART https://t.co/F6jlknqhu8
-
-
Mashup Score: 61CAR T-cell Therapy in Mantle Cell Lymphoma with Secondary CNS Involvement - a multicenter experience. - 9 month(s) ago
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T Awan, Alexandra E. Rojek, Peter A Riedell, Madiha Iqbal, Timothy S. Fen
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
CAR T-cell Therapy in Mantle cell with sCNS Involvement. Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance? @mshadman @gulrayzahmed @awandoc @timfenske @MadihaIqbal13 @MKD_BMT @MCWCancerCenter #lymsm #CART https://t.co/fjBAz6IrGo
-
-
Mashup Score: 58CAR T-cell Therapy in Mantle Cell Lymphoma with Secondary CNS Involvement - a multicenter experience. - 9 month(s) ago
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T Awan, Alexandra E. Rojek, Peter A Riedell, Madiha Iqbal, Timothy S. Fen
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
CAR T-cell Therapy in Mantle cell with sCNS Involvement. Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance? @mshadman @gulrayzahmed @awandoc @timfenske @MadihaIqbal13 @MKD_BMT @MCWCancerCenter #lymsm #CART https://t.co/fjBAz6IrGo
-
CAR-T for T cell malignancies: the future is bright! 👏🏾👏🏾 #lymsm #CART https://t.co/LP5iKukIVq